

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 9.66246878 |
| 2 | negative regulation of cAMP-mediated signaling (GO:0043951) | 8.52996958 |
| 3 | ether lipid metabolic process (GO:0046485) | 7.87091686 |
| 4 | opioid receptor signaling pathway (GO:0038003) | 7.72675883 |
| 5 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 7.50008042 |
| 6 | behavioral response to ethanol (GO:0048149) | 7.01144994 |
| 7 | regulation of protein glycosylation (GO:0060049) | 6.97465521 |
| 8 | regulation of acrosome reaction (GO:0060046) | 6.91402128 |
| 9 | regulation of translational termination (GO:0006449) | 6.41443858 |
| 10 | thrombin receptor signaling pathway (GO:0070493) | 6.29143283 |
| 11 | adult feeding behavior (GO:0008343) | 6.25464958 |
| 12 | complement activation, alternative pathway (GO:0006957) | 6.15458198 |
| 13 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 5.78943943 |
| 14 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 5.72872777 |
| 15 | negative regulation of glycoprotein metabolic process (GO:1903019) | 5.52176185 |
| 16 | regulation of triglyceride catabolic process (GO:0010896) | 5.43059481 |
| 17 | sphingosine metabolic process (GO:0006670) | 5.40757068 |
| 18 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.19322189 |
| 19 | positive regulation of cAMP-mediated signaling (GO:0043950) | 5.16429072 |
| 20 | urate metabolic process (GO:0046415) | 5.14421873 |
| 21 | epoxygenase P450 pathway (GO:0019373) | 5.09578859 |
| 22 | diol metabolic process (GO:0034311) | 5.09384784 |
| 23 | sphingoid metabolic process (GO:0046519) | 4.99996690 |
| 24 | phospholipid efflux (GO:0033700) | 4.92985859 |
| 25 | notochord development (GO:0030903) | 4.81160903 |
| 26 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 4.74108620 |
| 27 | piRNA metabolic process (GO:0034587) | 4.64805641 |
| 28 | glycerol ether metabolic process (GO:0006662) | 4.40938854 |
| 29 | regulation of complement activation (GO:0030449) | 4.27469018 |
| 30 | cell-cell junction maintenance (GO:0045217) | 4.20550804 |
| 31 | regulation of protein activation cascade (GO:2000257) | 4.11981930 |
| 32 | maintenance of gastrointestinal epithelium (GO:0030277) | 4.10718336 |
| 33 | ether metabolic process (GO:0018904) | 4.02078594 |
| 34 | neurotransmitter catabolic process (GO:0042135) | 3.95282665 |
| 35 | cellular response to ammonium ion (GO:0071242) | 3.92374396 |
| 36 | ncRNA catabolic process (GO:0034661) | 3.81228584 |
| 37 | regulation of cholesterol esterification (GO:0010872) | 3.77522340 |
| 38 | cell junction maintenance (GO:0034331) | 3.76780988 |
| 39 | sperm capacitation (GO:0048240) | 3.76438002 |
| 40 | mRNA cleavage (GO:0006379) | 3.76149948 |
| 41 | flavonoid metabolic process (GO:0009812) | 3.74703123 |
| 42 | regulation of guanylate cyclase activity (GO:0031282) | 3.74005051 |
| 43 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.71268480 |
| 44 | intestinal absorption (GO:0050892) | 3.71242742 |
| 45 | glycosphingolipid metabolic process (GO:0006687) | 3.70503066 |
| 46 | high-density lipoprotein particle remodeling (GO:0034375) | 3.69200673 |
| 47 | positive regulation of icosanoid secretion (GO:0032305) | 3.68709107 |
| 48 | cellular glucuronidation (GO:0052695) | 3.62580548 |
| 49 | drug metabolic process (GO:0017144) | 3.52461860 |
| 50 | auditory receptor cell differentiation (GO:0042491) | 3.46627111 |
| 51 | positive regulation of fatty acid transport (GO:2000193) | 3.46338423 |
| 52 | neurotransmitter biosynthetic process (GO:0042136) | 3.43365126 |
| 53 | glucuronate metabolic process (GO:0019585) | 3.43252409 |
| 54 | uronic acid metabolic process (GO:0006063) | 3.43252409 |
| 55 | signal complex assembly (GO:0007172) | 3.43236504 |
| 56 | regulation of lipoprotein metabolic process (GO:0050746) | 3.42482023 |
| 57 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 3.41905367 |
| 58 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.39124123 |
| 59 | negative regulation of inclusion body assembly (GO:0090084) | 3.39047102 |
| 60 | omega-hydroxylase P450 pathway (GO:0097267) | 3.36904966 |
| 61 | response to phenylpropanoid (GO:0080184) | 3.30138654 |
| 62 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.28462851 |
| 63 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.25198253 |
| 64 | renal system process involved in regulation of blood volume (GO:0001977) | 3.23050282 |
| 65 | positive regulation of megakaryocyte differentiation (GO:0045654) | 3.20150154 |
| 66 | angiotensin maturation (GO:0002003) | 3.16528738 |
| 67 | GDP-mannose metabolic process (GO:0019673) | 3.14114168 |
| 68 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.11998015 |
| 69 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.11110012 |
| 70 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.11110012 |
| 71 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.07846252 |
| 72 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.07846252 |
| 73 | reverse cholesterol transport (GO:0043691) | 3.07842836 |
| 74 | regulation of cAMP-mediated signaling (GO:0043949) | 3.04700993 |
| 75 | vitamin catabolic process (GO:0009111) | 3.03118356 |
| 76 | fat-soluble vitamin catabolic process (GO:0042363) | 3.03118356 |
| 77 | negative regulation of protein activation cascade (GO:2000258) | 2.99922991 |
| 78 | glomerular visceral epithelial cell development (GO:0072015) | 2.98856935 |
| 79 | regulation of glycoprotein biosynthetic process (GO:0010559) | 2.98408976 |
| 80 | regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358) | 2.97025708 |
| 81 | negative regulation of cell-matrix adhesion (GO:0001953) | 2.96605898 |
| 82 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.95771056 |
| 83 | regulation of keratinocyte proliferation (GO:0010837) | 2.91840596 |
| 84 | negative regulation of epidermal cell differentiation (GO:0045605) | 2.91438301 |
| 85 | drug catabolic process (GO:0042737) | 2.91261093 |
| 86 | positive regulation of guanylate cyclase activity (GO:0031284) | 2.90500839 |
| 87 | exogenous drug catabolic process (GO:0042738) | 2.89293278 |
| 88 | epithelial cell-cell adhesion (GO:0090136) | 2.89287128 |
| 89 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.87376574 |
| 90 | amyloid precursor protein metabolic process (GO:0042982) | 2.87267667 |
| 91 | regulation of glycoprotein metabolic process (GO:1903018) | 2.86278060 |
| 92 | regulation of respiratory burst (GO:0060263) | 2.86078991 |
| 93 | thyroid hormone generation (GO:0006590) | 2.84820744 |
| 94 | response to methylmercury (GO:0051597) | 2.84450210 |
| 95 | positive regulation of lipid catabolic process (GO:0050996) | 2.78442023 |
| 96 | histone H3 deacetylation (GO:0070932) | 2.77962247 |
| 97 | quinone biosynthetic process (GO:1901663) | 2.77834358 |
| 98 | negative regulation of complement activation (GO:0045916) | 2.77591776 |
| 99 | regulation of icosanoid secretion (GO:0032303) | 2.74723939 |
| 100 | epithelial structure maintenance (GO:0010669) | 2.74071941 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 4.28041874 |
| 2 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 3.01883832 |
| 3 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.87212228 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.81766197 |
| 5 | VDR_22108803_ChIP-Seq_LS180_Human | 2.46307377 |
| 6 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.40267941 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.28320410 |
| 8 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.26460519 |
| 9 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 2.26460519 |
| 10 | RXR_22108803_ChIP-Seq_LS180_Human | 2.20537170 |
| 11 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.14064931 |
| 12 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.07818788 |
| 13 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.02349537 |
| 14 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.98044551 |
| 15 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.96483344 |
| 16 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.94296728 |
| 17 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.92625853 |
| 18 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.87290228 |
| 19 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.84328520 |
| 20 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.81218393 |
| 21 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.79916307 |
| 22 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.78221759 |
| 23 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.76397077 |
| 24 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.76384219 |
| 25 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.74001929 |
| 26 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.72434662 |
| 27 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.71386532 |
| 28 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.61759885 |
| 29 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.61647916 |
| 30 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.58621227 |
| 31 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.57710799 |
| 32 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.55004262 |
| 33 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.54583437 |
| 34 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.53959730 |
| 35 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.52830020 |
| 36 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.52475905 |
| 37 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.51894707 |
| 38 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.50835077 |
| 39 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.50835077 |
| 40 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.46616198 |
| 41 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.45349843 |
| 42 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.44264087 |
| 43 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.43232486 |
| 44 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.40375574 |
| 45 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.39573083 |
| 46 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.36479870 |
| 47 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.36347165 |
| 48 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.35920612 |
| 49 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.35339035 |
| 50 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.33982769 |
| 51 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.33769223 |
| 52 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.29066308 |
| 53 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.28912761 |
| 54 | GATA1_22025678_ChIP-Seq_K562_Human | 1.22866367 |
| 55 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.22192185 |
| 56 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.21835312 |
| 57 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.21140847 |
| 58 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.20322518 |
| 59 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.18902560 |
| 60 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.18339293 |
| 61 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.15914063 |
| 62 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.15680554 |
| 63 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.14263163 |
| 64 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.12918016 |
| 65 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.12492070 |
| 66 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.12233862 |
| 67 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.11704020 |
| 68 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.11079995 |
| 69 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.11079995 |
| 70 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.09366939 |
| 71 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.08925649 |
| 72 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.08902657 |
| 73 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.08601449 |
| 74 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08258886 |
| 75 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.06167130 |
| 76 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.05983539 |
| 77 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.05609127 |
| 78 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.04740852 |
| 79 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.04728566 |
| 80 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04597477 |
| 81 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.03780123 |
| 82 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.03249844 |
| 83 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.01945115 |
| 84 | ERA_21632823_ChIP-Seq_H3396_Human | 1.00872746 |
| 85 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.99188584 |
| 86 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.98694861 |
| 87 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.97260656 |
| 88 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.96660663 |
| 89 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.96215308 |
| 90 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.95619815 |
| 91 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.94034016 |
| 92 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.93914028 |
| 93 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.93458290 |
| 94 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.92752333 |
| 95 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.92691031 |
| 96 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.92443565 |
| 97 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.92292109 |
| 98 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.91812513 |
| 99 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.91292731 |
| 100 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.89507529 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.91733794 |
| 2 | MP0002876_abnormal_thyroid_physiology | 5.36669509 |
| 3 | MP0009278_abnormal_bone_marrow | 4.02587531 |
| 4 | MP0009780_abnormal_chondrocyte_physiolo | 3.96437199 |
| 5 | MP0010234_abnormal_vibrissa_follicle | 3.66904568 |
| 6 | MP0009840_abnormal_foam_cell | 3.61499745 |
| 7 | MP0008872_abnormal_physiological_respon | 3.40723709 |
| 8 | MP0000678_abnormal_parathyroid_gland | 3.38898788 |
| 9 | MP0003183_abnormal_peptide_metabolism | 2.90720457 |
| 10 | MP0001664_abnormal_digestion | 2.87027079 |
| 11 | MP0001968_abnormal_touch/_nociception | 2.81840159 |
| 12 | MP0002796_impaired_skin_barrier | 2.48206886 |
| 13 | MP0004264_abnormal_extraembryonic_tissu | 2.45642187 |
| 14 | MP0005503_abnormal_tendon_morphology | 2.44379259 |
| 15 | MP0001501_abnormal_sleep_pattern | 2.34909045 |
| 16 | MP0003879_abnormal_hair_cell | 2.21765786 |
| 17 | MP0003941_abnormal_skin_development | 2.08593260 |
| 18 | MP0004147_increased_porphyrin_level | 2.05065638 |
| 19 | MP0005085_abnormal_gallbladder_physiolo | 1.89524724 |
| 20 | MP0009333_abnormal_splenocyte_physiolog | 1.88001604 |
| 21 | MP0009764_decreased_sensitivity_to | 1.85170455 |
| 22 | MP0002249_abnormal_larynx_morphology | 1.82614235 |
| 23 | MP0005365_abnormal_bile_salt | 1.74902993 |
| 24 | MP0005646_abnormal_pituitary_gland | 1.72093981 |
| 25 | MP0009384_cardiac_valve_regurgitation | 1.72008509 |
| 26 | MP0003638_abnormal_response/metabolism_ | 1.69335301 |
| 27 | MP0002098_abnormal_vibrissa_morphology | 1.66400531 |
| 28 | MP0000681_abnormal_thyroid_gland | 1.63897448 |
| 29 | MP0002139_abnormal_hepatobiliary_system | 1.59626650 |
| 30 | MP0005167_abnormal_blood-brain_barrier | 1.52748653 |
| 31 | MP0004782_abnormal_surfactant_physiolog | 1.49788088 |
| 32 | MP0005501_abnormal_skin_physiology | 1.49433737 |
| 33 | MP0001485_abnormal_pinna_reflex | 1.47986005 |
| 34 | MP0005670_abnormal_white_adipose | 1.47684410 |
| 35 | MP0003567_abnormal_fetal_cardiomyocyte | 1.43621323 |
| 36 | MP0010329_abnormal_lipoprotein_level | 1.43329010 |
| 37 | MP0004019_abnormal_vitamin_homeostasis | 1.42599329 |
| 38 | MP0001666_abnormal_nutrient_absorption | 1.41153748 |
| 39 | MP0009643_abnormal_urine_homeostasis | 1.38820379 |
| 40 | MP0001529_abnormal_vocalization | 1.33881400 |
| 41 | MP0005551_abnormal_eye_electrophysiolog | 1.27762325 |
| 42 | MP0001764_abnormal_homeostasis | 1.25889007 |
| 43 | MP0010155_abnormal_intestine_physiology | 1.24235437 |
| 44 | MP0008875_abnormal_xenobiotic_pharmacok | 1.22355886 |
| 45 | MP0003880_abnormal_central_pattern | 1.16350316 |
| 46 | MP0005332_abnormal_amino_acid | 1.14582026 |
| 47 | MP0000230_abnormal_systemic_arterial | 1.13925493 |
| 48 | MP0001545_abnormal_hematopoietic_system | 1.11159066 |
| 49 | MP0005397_hematopoietic_system_phenotyp | 1.11159066 |
| 50 | MP0000538_abnormal_urinary_bladder | 1.08323744 |
| 51 | MP0008789_abnormal_olfactory_epithelium | 1.06813356 |
| 52 | MP0003191_abnormal_cellular_cholesterol | 1.05157191 |
| 53 | MP0003045_fibrosis | 1.03492444 |
| 54 | MP0004858_abnormal_nervous_system | 1.00470094 |
| 55 | MP0003866_abnormal_defecation | 0.99971281 |
| 56 | MP0006035_abnormal_mitochondrial_morpho | 0.99607189 |
| 57 | MP0004043_abnormal_pH_regulation | 0.99277749 |
| 58 | MP0003718_maternal_effect | 0.96538994 |
| 59 | MP0002733_abnormal_thermal_nociception | 0.96201709 |
| 60 | MP0010771_integument_phenotype | 0.91088151 |
| 61 | MP0009765_abnormal_xenobiotic_induced | 0.90923089 |
| 62 | MP0002971_abnormal_brown_adipose | 0.88241839 |
| 63 | MP0001849_ear_inflammation | 0.86060632 |
| 64 | MP0001881_abnormal_mammary_gland | 0.82956220 |
| 65 | MP0003868_abnormal_feces_composition | 0.82481782 |
| 66 | MP0000490_abnormal_crypts_of | 0.80414171 |
| 67 | MP0003633_abnormal_nervous_system | 0.77568240 |
| 68 | MP0002136_abnormal_kidney_physiology | 0.77095169 |
| 69 | MP0001756_abnormal_urination | 0.76348868 |
| 70 | MP0005367_renal/urinary_system_phenotyp | 0.76298641 |
| 71 | MP0000516_abnormal_urinary_system | 0.76298641 |
| 72 | MP0000049_abnormal_middle_ear | 0.74620364 |
| 73 | MP0001919_abnormal_reproductive_system | 0.73386270 |
| 74 | MP0001765_abnormal_ion_homeostasis | 0.73197084 |
| 75 | MP0002118_abnormal_lipid_homeostasis | 0.71652167 |
| 76 | MP0005395_other_phenotype | 0.71174918 |
| 77 | MP0005636_abnormal_mineral_homeostasis | 0.69842358 |
| 78 | MP0002822_catalepsy | 0.69225757 |
| 79 | MP0000749_muscle_degeneration | 0.67434866 |
| 80 | MP0003195_calcinosis | 0.64360195 |
| 81 | MP0005310_abnormal_salivary_gland | 0.63127186 |
| 82 | MP0002282_abnormal_trachea_morphology | 0.62190336 |
| 83 | MP0001963_abnormal_hearing_physiology | 0.61065872 |
| 84 | MP0004085_abnormal_heartbeat | 0.59348083 |
| 85 | MP0003959_abnormal_lean_body | 0.59224377 |
| 86 | MP0003806_abnormal_nucleotide_metabolis | 0.59067986 |
| 87 | MP0005645_abnormal_hypothalamus_physiol | 0.59044926 |
| 88 | MP0002254_reproductive_system_inflammat | 0.58606826 |
| 89 | MP0001986_abnormal_taste_sensitivity | 0.58176652 |
| 90 | MP0001502_abnormal_circadian_rhythm | 0.55124792 |
| 91 | MP0004742_abnormal_vestibular_system | 0.54993101 |
| 92 | MP0001270_distended_abdomen | 0.54972722 |
| 93 | MP0002069_abnormal_eating/drinking_beha | 0.54302905 |
| 94 | MP0009672_abnormal_birth_weight | 0.53898713 |
| 95 | MP0006276_abnormal_autonomic_nervous | 0.52454626 |
| 96 | MP0000566_synostosis | 0.51522265 |
| 97 | MP0005319_abnormal_enzyme/_coenzyme | 0.51086520 |
| 98 | MP0000467_abnormal_esophagus_morphology | 0.50038002 |
| 99 | MP0005499_abnormal_olfactory_system | 0.48648906 |
| 100 | MP0005394_taste/olfaction_phenotype | 0.48648906 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.44812100 |
| 2 | Pancreatic islet-cell hyperplasia (HP:0004510) | 5.38493229 |
| 3 | Intestinal atresia (HP:0011100) | 5.34891655 |
| 4 | Hydroxyprolinuria (HP:0003080) | 4.99392791 |
| 5 | Abnormality of proline metabolism (HP:0010907) | 4.99392791 |
| 6 | Thickened helices (HP:0000391) | 4.85316052 |
| 7 | Abnormality of the aortic arch (HP:0012303) | 4.81933155 |
| 8 | Volvulus (HP:0002580) | 4.79775823 |
| 9 | Oligodontia (HP:0000677) | 4.71386274 |
| 10 | Broad alveolar ridges (HP:0000187) | 4.68519554 |
| 11 | Large for gestational age (HP:0001520) | 4.15109994 |
| 12 | Ileus (HP:0002595) | 4.04866771 |
| 13 | Congenital ichthyosiform erythroderma (HP:0007431) | 4.01720733 |
| 14 | Mesangial abnormality (HP:0001966) | 3.70181063 |
| 15 | Pili torti (HP:0003777) | 3.51936911 |
| 16 | Abnormal hair laboratory examination (HP:0003328) | 3.44096338 |
| 17 | Xanthomatosis (HP:0000991) | 3.38832141 |
| 18 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.36966244 |
| 19 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.36966244 |
| 20 | Tubular atrophy (HP:0000092) | 3.14319511 |
| 21 | Decreased circulating renin level (HP:0003351) | 3.14155181 |
| 22 | Agitation (HP:0000713) | 2.99477290 |
| 23 | Focal motor seizures (HP:0011153) | 2.97305397 |
| 24 | Hyperactive renin-angiotensin system (HP:0000841) | 2.86950718 |
| 25 | Poor head control (HP:0002421) | 2.86133088 |
| 26 | Gastrointestinal atresia (HP:0002589) | 2.83890384 |
| 27 | Gaze-evoked nystagmus (HP:0000640) | 2.79316317 |
| 28 | Malnutrition (HP:0004395) | 2.74817740 |
| 29 | Neonatal respiratory distress (HP:0002643) | 2.68173120 |
| 30 | Spontaneous abortion (HP:0005268) | 2.60105693 |
| 31 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.55553770 |
| 32 | Abnormality of glycine metabolism (HP:0010895) | 2.55553770 |
| 33 | Abnormality of renin-angiotensin system (HP:0000847) | 2.53197461 |
| 34 | Abdominal distention (HP:0003270) | 2.51370221 |
| 35 | Hypoplastic iliac wings (HP:0002866) | 2.44796062 |
| 36 | Hypoproteinemia (HP:0003075) | 2.40429956 |
| 37 | Poikiloderma (HP:0001029) | 2.40083906 |
| 38 | Abnormality of nail color (HP:0100643) | 2.40058468 |
| 39 | Lissencephaly (HP:0001339) | 2.38938300 |
| 40 | Hyperglycinuria (HP:0003108) | 2.38484572 |
| 41 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.38097114 |
| 42 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.38097114 |
| 43 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.38097114 |
| 44 | High anterior hairline (HP:0009890) | 2.37630811 |
| 45 | Hyperpituitarism (HP:0010514) | 2.36588931 |
| 46 | Azoospermia (HP:0000027) | 2.35087636 |
| 47 | Amelogenesis imperfecta (HP:0000705) | 2.33402553 |
| 48 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.33361154 |
| 49 | Mucopolysacchariduria (HP:0008155) | 2.33361154 |
| 50 | Abnormality of the ileum (HP:0001549) | 2.28609069 |
| 51 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.25593878 |
| 52 | Large eyes (HP:0001090) | 2.24301376 |
| 53 | Optic nerve hypoplasia (HP:0000609) | 2.23226701 |
| 54 | Conjugated hyperbilirubinemia (HP:0002908) | 2.23168672 |
| 55 | Focal segmental glomerulosclerosis (HP:0000097) | 2.20625948 |
| 56 | Alkalosis (HP:0001948) | 2.19685847 |
| 57 | Hemorrhage of the eye (HP:0011885) | 2.19284872 |
| 58 | Hypercortisolism (HP:0001578) | 2.18857384 |
| 59 | Metabolic alkalosis (HP:0200114) | 2.18844933 |
| 60 | Tented upper lip vermilion (HP:0010804) | 2.16767537 |
| 61 | Impulsivity (HP:0100710) | 2.14376785 |
| 62 | Abnormality of the alveolar ridges (HP:0006477) | 2.12262953 |
| 63 | Dysostosis multiplex (HP:0000943) | 2.08977347 |
| 64 | Abnormality of nucleobase metabolism (HP:0010932) | 2.08657439 |
| 65 | Myositis (HP:0100614) | 2.02169202 |
| 66 | Adrenal overactivity (HP:0002717) | 2.01240858 |
| 67 | Cerebellar dysplasia (HP:0007033) | 2.00980363 |
| 68 | Abnormality of purine metabolism (HP:0004352) | 2.00894904 |
| 69 | Thyroid-stimulating hormone excess (HP:0002925) | 10.6381981 |
| 70 | Choroideremia (HP:0001139) | 1.98168646 |
| 71 | Vascular calcification (HP:0004934) | 1.97973653 |
| 72 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.96450538 |
| 73 | Ectropion (HP:0000656) | 1.95938465 |
| 74 | Progressive inability to walk (HP:0002505) | 1.94937912 |
| 75 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.94563218 |
| 76 | Widely patent fontanelles and sutures (HP:0004492) | 1.93579001 |
| 77 | Syncope (HP:0001279) | 1.89830042 |
| 78 | J-shaped sella turcica (HP:0002680) | 1.89159406 |
| 79 | Orchitis (HP:0100796) | 1.86526637 |
| 80 | Flared iliac wings (HP:0002869) | 1.85969643 |
| 81 | Goiter (HP:0000853) | 1.85713998 |
| 82 | Congenital sensorineural hearing impairment (HP:0008527) | 1.85597639 |
| 83 | Nonprogressive disorder (HP:0003680) | 1.84559998 |
| 84 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.84104076 |
| 85 | Hypophosphatemic rickets (HP:0004912) | 1.83920677 |
| 86 | Hyperaldosteronism (HP:0000859) | 1.83624332 |
| 87 | Gastrointestinal dysmotility (HP:0002579) | 1.83395598 |
| 88 | Poor speech (HP:0002465) | 1.82887858 |
| 89 | Pigmentary retinal degeneration (HP:0001146) | 1.78736888 |
| 90 | Abnormality of the vitreous humor (HP:0004327) | 1.77335048 |
| 91 | Glomerulosclerosis (HP:0000096) | 1.74037903 |
| 92 | Hamartoma (HP:0010566) | 1.73812637 |
| 93 | Gout (HP:0001997) | 1.73633290 |
| 94 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.73324048 |
| 95 | Embryonal renal neoplasm (HP:0011794) | 1.73136913 |
| 96 | Neoplasm of the lung (HP:0100526) | 1.71933958 |
| 97 | Potter facies (HP:0002009) | 1.71433740 |
| 98 | Facial shape deformation (HP:0011334) | 1.71433740 |
| 99 | Breast hypoplasia (HP:0003187) | 1.68143011 |
| 100 | Short palpebral fissure (HP:0012745) | 1.68059247 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ADRBK2 | 7.88380062 |
| 2 | MST1R | 4.66890980 |
| 3 | ERN1 | 4.48042948 |
| 4 | IRAK1 | 4.16552316 |
| 5 | FRK | 3.82954576 |
| 6 | ACVR1B | 3.57218021 |
| 7 | CASK | 3.00709198 |
| 8 | EPHA2 | 2.67177487 |
| 9 | TSSK6 | 2.40938259 |
| 10 | PNCK | 2.32794936 |
| 11 | ADRBK1 | 2.25575798 |
| 12 | RIPK1 | 2.19963317 |
| 13 | IRAK3 | 2.18762309 |
| 14 | MET | 2.00357109 |
| 15 | STK38L | 1.84477270 |
| 16 | PINK1 | 1.82863524 |
| 17 | DYRK3 | 1.64957374 |
| 18 | EPHA4 | 1.55218094 |
| 19 | GRK1 | 1.54545625 |
| 20 | STK39 | 1.52597514 |
| 21 | NTRK3 | 1.48365330 |
| 22 | PRKCG | 1.33708572 |
| 23 | TGFBR1 | 1.30333853 |
| 24 | WEE1 | 1.24973823 |
| 25 | TYRO3 | 1.21860361 |
| 26 | OXSR1 | 1.19626144 |
| 27 | PRKCE | 1.19279090 |
| 28 | MELK | 1.18933738 |
| 29 | CLK1 | 1.17453711 |
| 30 | TIE1 | 1.16625119 |
| 31 | MST4 | 1.11454863 |
| 32 | PRKCI | 1.03330793 |
| 33 | MAPK15 | 1.02577536 |
| 34 | SIK1 | 1.01526894 |
| 35 | ERBB2 | 0.95386385 |
| 36 | MAP2K2 | 0.90679508 |
| 37 | DAPK2 | 0.89296026 |
| 38 | EPHB2 | 0.86870497 |
| 39 | MAP4K2 | 0.85985170 |
| 40 | STK24 | 0.78785641 |
| 41 | NUAK1 | 0.71907491 |
| 42 | PRKG2 | 0.70069146 |
| 43 | MAPKAPK5 | 0.69782838 |
| 44 | MAP2K6 | 0.66426573 |
| 45 | MAPKAPK3 | 0.65198898 |
| 46 | LMTK2 | 0.63884358 |
| 47 | NME1 | 0.61642206 |
| 48 | PIK3CA | 0.59225129 |
| 49 | STK38 | 0.58780217 |
| 50 | DYRK1A | 0.56577665 |
| 51 | PTK2B | 0.55919152 |
| 52 | MAPK11 | 0.53565039 |
| 53 | BMPR1B | 0.51501678 |
| 54 | TLK1 | 0.49810109 |
| 55 | MKNK2 | 0.49074869 |
| 56 | ILK | 0.46576138 |
| 57 | PTK6 | 0.45327804 |
| 58 | PKN2 | 0.44107987 |
| 59 | STK3 | 0.43747977 |
| 60 | FLT3 | 0.42133100 |
| 61 | CAMK2A | 0.39514279 |
| 62 | PRKCA | 0.34283427 |
| 63 | PRKCB | 0.31789300 |
| 64 | CSNK1E | 0.31776878 |
| 65 | ZAP70 | 0.31103145 |
| 66 | PDPK1 | 0.28238898 |
| 67 | LATS2 | 0.27939830 |
| 68 | MAPK13 | 0.27679558 |
| 69 | PRKACG | 0.26141449 |
| 70 | DYRK1B | 0.25452771 |
| 71 | ICK | 0.25259743 |
| 72 | SIK3 | 0.24831319 |
| 73 | STK10 | 0.23726597 |
| 74 | ROCK1 | 0.23274622 |
| 75 | NME2 | 0.21136732 |
| 76 | CAMK4 | 0.20999067 |
| 77 | PRKCZ | 0.20934587 |
| 78 | FER | 0.20370146 |
| 79 | PDK1 | 0.18897105 |
| 80 | CDC42BPA | 0.18445067 |
| 81 | GRK5 | 0.18336922 |
| 82 | PRKACA | 0.18147951 |
| 83 | MAPK1 | 0.17294736 |
| 84 | MAPK3 | 0.16895925 |
| 85 | MAPK8 | 0.16873837 |
| 86 | MKNK1 | 0.15432984 |
| 87 | MAP2K1 | 0.15081602 |
| 88 | MATK | 0.13833379 |
| 89 | MAP3K8 | 0.13716302 |
| 90 | PIK3CG | 0.13635504 |
| 91 | BRAF | 0.12371235 |
| 92 | CSF1R | 0.12180986 |
| 93 | YES1 | 0.11257314 |
| 94 | PRKCQ | 0.11091799 |
| 95 | BMX | 0.11073075 |
| 96 | NEK2 | 0.11017964 |
| 97 | WNK4 | 0.10891947 |
| 98 | RPS6KA6 | 0.10342117 |
| 99 | CAMK1 | 0.10040698 |
| 100 | DAPK1 | 0.09850118 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 5.26014182 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.10694800 |
| 3 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.98825911 |
| 4 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.92021229 |
| 5 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.83798583 |
| 6 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.50803467 |
| 7 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.36266700 |
| 8 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.35228686 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.30965258 |
| 10 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.09329620 |
| 11 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.04938393 |
| 12 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.04035447 |
| 13 | Retinol metabolism_Homo sapiens_hsa00830 | 2.02819457 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.01175710 |
| 15 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.97363785 |
| 16 | Histidine metabolism_Homo sapiens_hsa00340 | 1.96141600 |
| 17 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.94328863 |
| 18 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.92603195 |
| 19 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.91404684 |
| 20 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.86389309 |
| 21 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.85792449 |
| 22 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.85304005 |
| 23 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.79369671 |
| 24 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.77896870 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.73826457 |
| 26 | Prion diseases_Homo sapiens_hsa05020 | 1.72477147 |
| 27 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.72032224 |
| 28 | Mineral absorption_Homo sapiens_hsa04978 | 1.71660904 |
| 29 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.62372409 |
| 30 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.57787141 |
| 31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.57425047 |
| 32 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.56838098 |
| 33 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.55740420 |
| 34 | ABC transporters_Homo sapiens_hsa02010 | 1.46926252 |
| 35 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.44283892 |
| 36 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.41780321 |
| 37 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.28605199 |
| 38 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.18590872 |
| 39 | Sulfur relay system_Homo sapiens_hsa04122 | 1.18222228 |
| 40 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.16995403 |
| 41 | Olfactory transduction_Homo sapiens_hsa04740 | 1.14308344 |
| 42 | Bile secretion_Homo sapiens_hsa04976 | 1.12762985 |
| 43 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.11482708 |
| 44 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.09649989 |
| 45 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.08732110 |
| 46 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.06442429 |
| 47 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.02755963 |
| 48 | Other glycan degradation_Homo sapiens_hsa00511 | 1.02688487 |
| 49 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.01661044 |
| 50 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.95106358 |
| 51 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.94263920 |
| 52 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.91014167 |
| 53 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.89548109 |
| 54 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.85804631 |
| 55 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.84910859 |
| 56 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.80928094 |
| 57 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.80047637 |
| 58 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.78556093 |
| 59 | Galactose metabolism_Homo sapiens_hsa00052 | 0.76909694 |
| 60 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.69813274 |
| 61 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.69500103 |
| 62 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.66625003 |
| 63 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.63114058 |
| 64 | Phototransduction_Homo sapiens_hsa04744 | 0.62112598 |
| 65 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.61659751 |
| 66 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.61583159 |
| 67 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.61246052 |
| 68 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.59404369 |
| 69 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.59263542 |
| 70 | Taste transduction_Homo sapiens_hsa04742 | 0.56026654 |
| 71 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.51091678 |
| 72 | Peroxisome_Homo sapiens_hsa04146 | 0.47735755 |
| 73 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.46938596 |
| 74 | Morphine addiction_Homo sapiens_hsa05032 | 0.46832795 |
| 75 | Metabolic pathways_Homo sapiens_hsa01100 | 0.43243629 |
| 76 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.42925986 |
| 77 | Lysosome_Homo sapiens_hsa04142 | 0.31199994 |
| 78 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.31102889 |
| 79 | Salivary secretion_Homo sapiens_hsa04970 | 0.28070211 |
| 80 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.26979095 |
| 81 | Circadian entrainment_Homo sapiens_hsa04713 | 0.26805123 |
| 82 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.25437250 |
| 83 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.24741823 |
| 84 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.23189538 |
| 85 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.22541701 |
| 86 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.19395179 |
| 87 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.18313241 |
| 88 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.15808739 |
| 89 | Tight junction_Homo sapiens_hsa04530 | 0.13649188 |
| 90 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.11589456 |
| 91 | Axon guidance_Homo sapiens_hsa04360 | 0.09599139 |
| 92 | Legionellosis_Homo sapiens_hsa05134 | 0.08987285 |
| 93 | Renin secretion_Homo sapiens_hsa04924 | 0.08426817 |
| 94 | Insulin secretion_Homo sapiens_hsa04911 | 0.07891290 |
| 95 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.07725894 |
| 96 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.06360383 |
| 97 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.03977616 |
| 98 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.03093845 |
| 99 | Amoebiasis_Homo sapiens_hsa05146 | 0.02044771 |
| 100 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.01862711 |

